Sonia Razzetti
About Sonia Razzetti
Sonia Razzetti is the SVP of Quality with a Ph.D. in Biological Sciences in Public Health from Harvard, known for her expertise in CMC product control strategy, compliance, and operations management.
Title: SVP, Quality
Sonia Razzetti currently serves as the Senior Vice President (SVP) of Quality. In this role, she is responsible for overseeing quality assurance, ensuring compliance with industry regulations, and maintaining high standards across product development cycles. Her leadership in quality management focuses on establishing robust control strategies and driving operational excellence.
Education and Expertise in Biological Sciences
Sonia Razzetti holds a Ph.D. in Biological Sciences in Public Health from Harvard Graduate School of Arts and Sciences. Her advanced education provides a solid foundation in public health and biological sciences, equipping her with the knowledge to support complex product control strategies and compliance frameworks within the pharmaceutical sector.
Professional Background in Quality and Operations
Before her current role, Sonia Razzetti served as the SVP of Quality and Operations at Generation Bio. Her professional journey includes ascending quality positions at various influential companies such as Biogen, Shire, Sanofi, and Ironwood Pharmaceuticals. These roles have enabled her to develop a deep expertise in compliance, product control strategy, and operations management.
Contribution to Therapeutics Development
Sonia Razzetti has supported the development and commercialization of several life-altering therapies, including LINZESS, VPRIV, ELAPRASE, and FIRAZYR. Her contributions have been instrumental in bringing these therapies to market, ensuring they meet stringent quality and compliance standards. Her work in this area demonstrates a strong commitment to improving patient outcomes through innovative therapeutics.